VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > 👏Ventripoint the potential here is really something.📍🚀

<< Previous

Bullboard Posts

Next >>

Comment by jopatcloon Oct 23, 2024 10:05am

25 Views

Post# 36278344

RE:RE:👏Ventripoint the potential here is really something.📍🚀

For those new to Ventripoint, Topper00 puppet of Granham the vulture or another of the many fake accounts of this guy who denigrates Ventripoint! It's up to you to judge who to believe? Interesting as usual, look who is trying to denigrate the good news. ( Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.) just filed 2 reports. View full report: SEDI:VPT #insiders/victor-johan-hugo Common Shares 16 - Acquisition or disposition under a prospectus exemption $16,215 +83,156 vol $0.195 each 83,156) See very positif (Ventripoint selected as a trusted solution for cardiac imaging; presented at Take Heart conference.) see the video The Ollie Hinkle Foundation posted videos of their Take Heart 2024 conference on YouTube. In the first session Dr. Soriano of Seattle Children's Hospital provides a very nice overview of VMS+ and its benefits to patients and care providers.https://www.youtube.com/watch?app=desktop&v=Ucu6uGRMtEs *Dr.Brian Soriano MD , FASE | Cardiologist, Associate Professor, Cardiology, and Adjunct Associate Professor, Radiology, Seattle Children’s Hospital I think they know more about the Ventripoint tech than the whiners on this board. Tic..tac.. November is coming!Europe V4.0 and Sales at any time now Insiders know!and FDA V4.0 soon ti..tac... The BEST automation and analysis of the PLANET GEN3EHO (Remember On Ascend website https://ascendcv.com/ Clic On integration see Ventripoint - The integration of Gen3Echo with Ventripoint's innovative application of AI to echocardiography) Interesting For those who continue their negative posts about Ventripoint like better out then in! See *Dr.Brian Soriano MD, FASE | Cardiologist, Associate Professor, Cardiology, and Adjunct Associate Professor, Radiology, Seattle Children’s Hospital *Dr Skinner, Consultant Pediatric Cardiologist from the University Hospital Leicester. *Dr. Laser is the Deputy Director and Senior Physician of the Department of Pediatric Cardiology and Congenital Heart Defects of Herz-und Diabeteszentrium North Rhine-Westfalia. *Dr. Howard Leong-Poi is Head of the Division of Cardiology, as well as the Medical Director of the Heart and Vascular Program at St. Michael’s Hospital in Toronto, Ontario. *Dr.Luc Mertens Medical Director of Echocardiography The Hospital for Sick Children, Toronto, CA *Dr.Brian Soriano MD, FASE | Cardiologist, Associate Professor, Cardiology, and Adjunct Associate Professor, Radiology, Seattle Children’s Hospital *Dr.Jeffrey Soble on the Ventripoint website “Our goal is that by working together, we can ultimately provide reliable and effective tools to clinicians globally.” Jeffrey Soble, MD CEO ASCEND https://ventripoint.com/